Univariate analysis identified a high LDH value (P = .001) and high DIC score on admission (P = .006), fever preceding induction therapy (P = .012), and MYCN amplification (P = .003) as possible risk factors of ARE in patients with newly diagnosed neuroblastoma (Table 3). The gene discussed is MYCN; the disease is neuroblastoma.